|
GB725228A
(en)
|
1952-06-19 |
1955-03-02 |
Roche Products Ltd |
Substituted carbamic acid esters and process for the manufacture thereof
|
|
BE640616A
(https=)
|
1962-12-19 |
|
|
|
|
NL130759C
(https=)
|
1965-10-07 |
|
|
|
|
US3492397A
(en)
|
1967-04-07 |
1970-01-27 |
Warner Lambert Pharmaceutical |
Sustained release dosage in the pellet form and process thereof
|
|
US4060598A
(en)
|
1967-06-28 |
1977-11-29 |
Boehringer Mannheim G.M.B.H. |
Tablets coated with aqueous resin dispersions
|
|
US3538214A
(en)
|
1969-04-22 |
1970-11-03 |
Merck & Co Inc |
Controlled release medicinal tablets
|
|
US4173626A
(en)
|
1978-12-11 |
1979-11-06 |
Merck & Co., Inc. |
Sustained release indomethacin
|
|
US4593034A
(en)
|
1984-04-06 |
1986-06-03 |
A. H. Robins Company, Inc. |
2-alkoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamides and thiobenzamides
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
IE62231B1
(en)
|
1987-12-24 |
1995-01-11 |
Wyeth John & Brother Ltd |
Heterocyclic compounds
|
|
DE3878235T2
(de)
|
1988-08-04 |
1993-06-03 |
Synthelabo |
Antischizophren-wirksame s-n-(1-azabicyclo (2.2.2.)oct-3-yl)benzamide und thiobenzamide.
|
|
US5549892A
(en)
|
1988-12-23 |
1996-08-27 |
Genzyme Corporation |
Enhanced in vivo uptake of glucocerebrosidase
|
|
US5236838A
(en)
|
1988-12-23 |
1993-08-17 |
Genzyme Corporation |
Enzymatically active recombinant glucocerebrosidase
|
|
IT1228293B
(it)
|
1989-02-06 |
1991-06-07 |
Angeli Inst Spa |
Benzoderivati di composti eterociclici contenenti azoto.
|
|
DK443489D0
(da)
|
1989-09-08 |
1989-09-08 |
Ferrosan As |
Substituerede urinstofforbindelser, deres fremstilling og anvendelse
|
|
US5272071A
(en)
|
1989-12-22 |
1993-12-21 |
Applied Research Systems Ars Holding N.V. |
Method for the modification of the expression characteristics of an endogenous gene of a given cell line
|
|
GB9106571D0
(en)
|
1991-03-27 |
1991-05-15 |
Erba Carlo Spa |
Derivatives of substituted imidazol-2-one and process for their preparation
|
|
US5733761A
(en)
|
1991-11-05 |
1998-03-31 |
Transkaryotic Therapies, Inc. |
Protein production and protein delivery
|
|
DE4326510A1
(de)
|
1993-08-06 |
1995-02-09 |
Bayer Ag |
Verfahren zur Herstellung von Cyclohexen-Derivaten
|
|
WO1995021820A1
(en)
|
1994-02-10 |
1995-08-17 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel carbamate derivative and medicinal composition containing the same
|
|
JPH08198751A
(ja)
|
1995-01-19 |
1996-08-06 |
Yamanouchi Pharmaceut Co Ltd |
カルバメート誘導体
|
|
US5668144A
(en)
|
1995-11-08 |
1997-09-16 |
American Home Products Corporation |
1-azabicyclopheptane derivatives
|
|
SE9600683D0
(sv)
|
1996-02-23 |
1996-02-23 |
Astra Ab |
Azabicyclic esters of carbamic acids useful in therapy
|
|
SK4699A3
(en)
|
1996-07-29 |
2000-04-10 |
Pharmacia & Upjohn Ab |
Arylcycloalkane carboxylic esters, their use, pharmaceutical compositions and preparation
|
|
IL135578A0
(en)
|
1997-10-29 |
2001-05-20 |
Genzyme Corp |
Compositions and methods for treating lysosomal storage disease
|
|
US5985836A
(en)
|
1998-07-31 |
1999-11-16 |
Bayer Corporation |
Alpha-1 proteinase inhibitor binding peptides
|
|
CN1332726A
(zh)
|
1998-11-02 |
2002-01-23 |
卫福有限公司 |
吡咯烷化合物及其药物用途
|
|
US6953855B2
(en)
|
1998-12-11 |
2005-10-11 |
Targacept, Inc. |
3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
|
|
JP2002540203A
(ja)
|
1999-03-29 |
2002-11-26 |
ニューロゲン コーポレイション |
Ｎｋ−３および／またはｇａｂａ（ａ）受容体リガンドとしての４−置換キノリン誘導体
|
|
FR2791678B1
(fr)
|
1999-03-30 |
2001-05-04 |
Synthelabo |
Derives de 1,4-diazabicyclo [3.2.2] nonane-4-carboxylates et -carboxamides, leur preparation et leur application en therapeutique
|
|
JP2003521543A
(ja)
|
2000-02-07 |
2003-07-15 |
アボット ゲーエムベーハー ウント カンパニー カーゲー |
２−ベンゾチアゾリル尿素誘導体およびそのプロテインキナーゼ阻害剤としての使用
|
|
GB0010955D0
(en)
|
2000-05-05 |
2000-06-28 |
Novartis Ag |
Organic compounds
|
|
CZ294251B6
(cs)
|
2000-06-27 |
2004-11-10 |
Laboratorios S. A. L. V. A. T., S. A. |
Karbamáty a jejich použití pro výrobu farmaceutického prostředku
|
|
KR100827937B1
(ko)
|
2000-07-19 |
2008-05-09 |
유니티카 가부시끼가이샤 |
스핑고당지질을 함유하는 생리학적 기능성 식품 또는화장품 및 이들의 제조방법
|
|
US6492386B2
(en)
|
2000-08-18 |
2002-12-10 |
Pharmacia & Upjohn Company |
Quinuclidine-substituted aryl compounds for treatment of disease
|
|
US6599916B2
(en)
|
2000-08-21 |
2003-07-29 |
Pharmacia & Upjohn Company |
Quinuclidine-substituted heteroaryl moieties for treatment of disease
|
|
JP4445704B2
(ja)
|
2000-12-22 |
2010-04-07 |
アルミラル・ソシエダッド・アノニマ |
キヌクリジンカルバメート誘導体およびｍ３アンダゴニストとしてのそれらの使用
|
|
DE60216830T2
(de)
|
2001-02-06 |
2007-06-14 |
Pfizer Products Inc., Groton |
Pharmazeutische Zusammensetzungen zur Behandlung von Störungen des ZNS oder anderen Erkrankungen
|
|
JP2003267977A
(ja)
|
2002-03-14 |
2003-09-25 |
Yamanouchi Pharmaceut Co Ltd |
キヌクリジン誘導体
|
|
DE10211415A1
(de)
|
2002-03-15 |
2003-09-25 |
Bayer Ag |
Bicyclische N-Biarylamide
|
|
ES2203327B1
(es)
|
2002-06-21 |
2005-06-16 |
Almirall Prodesfarma, S.A. |
Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen.
|
|
AU2003246942B2
(en)
|
2002-07-17 |
2009-06-25 |
Idorsia Pharmaceuticals Ltd |
Piperidinetriol derivatives as inhibitors of glycosylceramide synthase
|
|
JPWO2004011430A1
(ja)
|
2002-07-25 |
2005-11-24 |
アステラス製薬株式会社 |
ナトリウムチャネル阻害剤
|
|
SE0202430D0
(sv)
|
2002-08-14 |
2002-08-14 |
Astrazeneca Ab |
New Compounds
|
|
WO2004052365A2
(en)
|
2002-12-06 |
2004-06-24 |
North Shore-Long Island Jewish Research Institute |
Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists
|
|
WO2004056744A1
(en)
|
2002-12-23 |
2004-07-08 |
Janssen Pharmaceutica N.V. |
Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors
|
|
US20050031683A1
(en)
|
2003-08-04 |
2005-02-10 |
Ashish Kapoor |
Solid pharmaceutical composition
|
|
TW200529860A
(en)
|
2003-12-22 |
2005-09-16 |
Astrazeneca Ab |
Nicotinic acetylcholine receptor ligands
|
|
GB0400812D0
(en)
|
2004-01-14 |
2004-02-18 |
Celltech R&D Ltd |
Novel compounds
|
|
JP2007186422A
(ja)
|
2004-01-28 |
2007-07-26 |
Astellas Pharma Inc |
アリールスルフィド誘導体
|
|
AU2005258274A1
(en)
|
2004-06-23 |
2006-01-05 |
The Feinstein For Medical Research |
Method of treating ileus by pharmacological activation of cholinergic receptors
|
|
US8003617B2
(en)
|
2004-11-10 |
2011-08-23 |
Genzyme Corporation |
Methods of treating diabetes mellitus
|
|
WO2006134318A1
(en)
|
2005-06-11 |
2006-12-21 |
Vernalis R & D Limited |
Pyrazole-substituted benzimidazole derivatives for use in the treatment of cancer and autoimmune disorders
|
|
AU2006295397A1
(en)
|
2005-09-23 |
2007-04-05 |
Memory Pharmaceuticals Corporation |
Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
|
|
SG131819A1
(en)
|
2005-11-07 |
2007-05-28 |
Chikka Pte Ltd |
Buddy-based cross-carrier messaging system
|
|
US20090170847A1
(en)
|
2006-01-23 |
2009-07-02 |
Seung Chul Lee |
Imidazopyridine Derivatives Inhibiting Protein Kinase Activity, Method for the Preparation Thereof and Pharmaceutical Composition Containing Same
|
|
WO2007100430A2
(en)
|
2006-01-27 |
2007-09-07 |
Yale University |
Cytisine and acetylcholine analogs and methods of treating mood disorders
|
|
US7840109B2
(en)
|
2006-08-14 |
2010-11-23 |
Adc Telecommunications, Inc. |
Factory spliced cable assembly
|
|
KR20090107567A
(ko)
|
2007-02-09 |
2009-10-13 |
아스텔라스세이야쿠 가부시키가이샤 |
아자 가교환 화합물
|
|
CN101627014B
(zh)
|
2007-03-09 |
2013-04-24 |
株式会社绿十字 |
用于预防或治疗帕金森病的(+)-3-羟基吗啡喃的口服可生物利用前药
|
|
AU2008232614A1
(en)
|
2007-03-30 |
2008-10-09 |
Amicus Therapeutics, Inc. |
Method for the treatment of Fabry disease using pharmacological chaperones
|
|
EP2546232A1
(en)
|
2007-06-20 |
2013-01-16 |
Merck Sharp & Dohme Corp. |
Diphenyl Substituted Alkanes
|
|
BRPI0822349A2
(pt)
|
2007-11-29 |
2019-09-24 |
Neuraltus Pharmaceuticals Inc |
composições e métodos para tratar doenças lisossômicas
|
|
CA2731685A1
(en)
|
2008-07-28 |
2010-02-04 |
Genzyme Corporation |
Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and other glomerular disease
|
|
EP2154136A1
(en)
|
2008-08-08 |
2010-02-17 |
CHIESI FARMACEUTICI S.p.A. |
Quinuclidine carbonate derivatives and medicinal compositions thereof
|
|
WO2010091164A1
(en)
|
2009-02-06 |
2010-08-12 |
Exelixis, Inc. |
Inhibitors of glucosylceramide synthase
|
|
WO2010091104A1
(en)
|
2009-02-06 |
2010-08-12 |
Exelixis, Inc. |
Glucosylceramide synthase inhibitors
|
|
WO2010121963A1
(en)
|
2009-04-21 |
2010-10-28 |
Nerviano Medical Sciences S.R.L. |
Resorcinol derivatives as hsp90 inhibitors
|
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
|
CN102573842A
(zh)
|
2009-07-23 |
2012-07-11 |
诺瓦提斯公司 |
氮杂双环烷基衍生物或吡咯烷-2-酮衍生物的用途
|
|
SI3998078T1
(sl)
|
2009-08-28 |
2026-02-27 |
Genzyme Corporation |
Encimsko nadomestno zdravljenje z naraščajočim odmerkom za zdravljenje pomanjkanja kisle sfingomielinaze
|
|
US20110183938A1
(en)
|
2009-12-16 |
2011-07-28 |
Genentech, Inc. |
1,7-diazacarbazoles and methods of use
|
|
PT2568970T
(pt)
|
2010-05-10 |
2019-02-11 |
Lesvi Laboratorios Sl |
Formulações farmacêuticas estáveis contendo um anti-histamínico
|
|
RU2436782C1
(ru)
|
2010-06-10 |
2011-12-20 |
Новосибирский институт органической химии им. Н.Н. Ворожцова Сибирского отделения Российской академии наук (НИОХ СО РАН) |
2-МЕТОКСИ-4[(3aR,7aS)-3,3,6-ТРИМЕТИЛ-1,3,3a,4,5,7a-ГЕКСАГИДРО-2-БЕНЗОФУРАН-1-ИЛ]ФЕНОЛ - НОВОЕ СРЕДСТВО ДЛЯ ЛЕЧЕНИЯ БОЛЕЗНИ ПАРКИНСОНА
|
|
RU2607084C2
(ru)
|
2010-11-12 |
2017-01-10 |
Сионоги Энд Ко., Лтд. |
Кристаллы производных 6,7-ненасыщенного-7-карбамоилморфинана и способ их получения
|
|
AU2012231275A1
(en)
|
2011-03-18 |
2013-10-17 |
Genzyme Corporation |
Glucosylceramide synthase inhibitors
|
|
WO2012177997A1
(en)
|
2011-06-22 |
2012-12-27 |
The General Hospital Corporation |
Treatment of proteinopathies
|
|
US20140228575A1
(en)
|
2011-06-22 |
2014-08-14 |
Isochem |
Process for the Preparation of Solifenacin and Salts Thereof
|
|
HK1207006A1
(en)
|
2012-09-11 |
2016-01-22 |
Hospira Australia Pty Ltd |
Daptomycin formulations and uses thereof
|
|
MA37975B2
(fr)
|
2012-09-11 |
2021-03-31 |
Genzyme Corp |
Inhibiteurs de synthase de glucosylcéramide
|
|
JO3713B1
(ar)
|
2013-03-15 |
2021-01-31 |
Genzyme Corp |
أشكال ملح (s)-كوينوكليدين-3-يل(2-(2-(4-فلوروفينيل)ثيازول-4-يل)بروبان-2-يل)كارباميت
|
|
TWI649317B
(zh)
|
2013-03-15 |
2019-02-01 |
健臻公司 |
製備葡糖基神經醯胺合成酶抑制劑之方法
|
|
PT3079695T
(pt)
|
2013-12-11 |
2021-05-04 |
Genzyme Corp |
Inibidores de glicosilceramida-sintase
|
|
TW201642855A
(zh)
|
2015-03-10 |
2016-12-16 |
健臻公司 |
用於治療蛋白質病變之方法
|
|
EA201891170A1
(ru)
*
|
2015-11-18 |
2018-11-30 |
Джензим Корпорейшн |
Биомаркер поликистозной болезни почек и варианты его применения
|
|
EP3412296B1
(en)
|
2016-02-05 |
2025-11-12 |
Kyungpook National University Industry-Academic Cooperation Foundation |
Pharmaceutical composition containing stem cell in which vascular endothelial growth factor is overexpressed as effective ingredient for preventing or treating neurodegenerative disease
|
|
EP3452045A1
(en)
|
2016-05-04 |
2019-03-13 |
Lysosomal Therapeutics Inc. |
Methods of treatment and combination therapies using gcase activator heterobicyclic and related compounds
|
|
EP3318277A1
(en)
|
2016-11-04 |
2018-05-09 |
Institut du Cerveau et de la Moelle Epiniere-ICM |
Inhibitors of glucosylceramide synthase for the treatment of motor neuron diseases
|
|
US10588888B2
(en)
|
2017-07-17 |
2020-03-17 |
Children's Hospital Medical Center |
CNS-accessible pharmacological chaperones for treatment of acid β-glucosidase-related disease states
|
|
US12472144B2
(en)
|
2017-08-08 |
2025-11-18 |
Amneal Pharmaceuticals Llc |
Pharmaceutical composition comprising eliglustat
|
|
US10519157B2
(en)
|
2018-02-09 |
2019-12-31 |
X-Cutag Therapeutics, Inc. |
Deuterated compounds for treating Fabry, Gaucher, Parkinson's and related diseases and conditions, and compositions and methods thereof
|
|
EP3920924A4
(en)
|
2019-02-04 |
2022-11-16 |
Prilenia Neurotherapeutics Ltd. |
LOW-DOSE PRIDOIDIN FOR THE TREATMENT OF PARKINSON'S DISEASE AND OTHER PARKINSONIC-RELATED DISEASES
|
|
CN114040762A
(zh)
|
2019-02-04 |
2022-02-11 |
建新公司 |
使用葡糖神经酰胺合酶(gcs)的抑制剂治疗纤毛疾病
|
|
AU2020218496B2
(en)
|
2019-02-04 |
2024-12-19 |
Genzyme Corporation |
Methods for treating symptoms and disorders associated with lysosomal storage diseases
|
|
EP4034256B1
(en)
|
2019-09-25 |
2025-11-19 |
Assia Chemical Industries Ltd. |
Solid state forms of lucerastat salts and process for preparation thereof
|
|
TW202142236A
(zh)
|
2020-02-03 |
2021-11-16 |
美商健臻公司 |
用於治療與溶體儲積症相關的神經症狀之方法
|
|
KR20230043024A
(ko)
|
2020-07-24 |
2023-03-30 |
젠자임 코포레이션 |
벤글루스타트를 포함하는 제약 조성물
|
|
EP4188381A1
(en)
|
2020-07-30 |
2023-06-07 |
Genzyme Corporation |
Methods for reducing glycosphingolipid concentration in brain tissue and methods of treatment of neurodegenerative diseases involving the same
|